Glycan determinants synthesized by specific glycosyltransferases play defined roles in development, cancer progression, metastasis, immunity and Notch signal transduction. In order to understand new and conserved functions of sugars in biology, the repertoire of glycan structures synthesized by model organisms (the glycome) must be defined. Genes that encode glycosyltransferases that produce the glycome must be isolated and the biochemical activities of their producs determined. The approximately 50 independent CHO glycosylation mutants that we have characterized under the auspices of this grant provide unique access to glycomes and to functional glycomics. Mutants with an established glycosylation defect have proved extremely useful for expression cloning glycosylation genes, for determining lectin binding specificities, and, most recently, for showing that fringe is a novel glycosyltransferase that directly modifies Notch and thereby inhibits Jagged-1-induced Notch signaling. We now propose to use CHO cells and the CHO glycosylation mutants to identify the activity of """"""""orphan"""""""" glycosyltransferases predicted from genome and mutation database searches. The focus will be on glycosyltransferases that modulate Notch signaling in the CHO co-culture assay and those whose acceptor specificity is highly conserved across species. The corresponding glycosyltransferase genes will be functionally localized in developmental and signaling pathways by characterizing existing mutants or by gene silencing and antisense techniques in Drosophila, C. elegans and/or zebrafish. In a second aim, the number of CHO glycosylation mutants available for experiments in functional glycomics will be expanded by determining the biochemical defect and genetic basis of previously isolated loss- and gain-of-function CHO glycosylation mutants using rapid analytical methods and retrovirus expression cloning. Thirdly, the entire panel of CHO glycosylation mutants and certain glycosyltransferase gene transfectants which present a wide variety of multivalent, differentially galactosylated cell surface environments, will be used to characterize binding and functional interactions of galectins 1, 2, 3 and 4, which represent three distinct structural types of galectin.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA036434-20
Application #
6621940
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Woodhouse, Elizabeth
Project Start
1984-01-01
Project End
2006-12-31
Budget Start
2003-01-14
Budget End
2003-12-31
Support Year
20
Fiscal Year
2003
Total Cost
$399,046
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
071036636
City
Bronx
State
NY
Country
United States
Zip Code
10461
Dong, Zhizhong; Zuber, Christian; Pierce, Michael et al. (2014) Reduction in Golgi apparatus dimension in the absence of a residential protein, N-acetylglucosaminyltransferase V. Histochem Cell Biol 141:153-64
Müller, Reto; Jenny, Andreas; Stanley, Pamela (2013) The EGF repeat-specific O-GlcNAc-transferase Eogt interacts with notch signaling and pyrimidine metabolism pathways in Drosophila. PLoS One 8:e62835
Miwa, Hazuki E; Koba, Wade R; Fine, Eugene J et al. (2013) Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer. Glycobiology 23:1477-90
Miwa, Hazuki E; Song, Yinghui; Alvarez, Richard et al. (2012) The bisecting GlcNAc in cell growth control and tumor progression. Glycoconj J 29:609-18
Zheng, Tianqing; Jiang, Hao; Gros, Marilyn et al. (2011) Tracking N-acetyllactosamine on cell-surface glycans in vivo. Angew Chem Int Ed Engl 50:4113-8
Varki, Ajit; Cummings, Richard D; Esko, Jeffrey D et al. (2009) Symbol nomenclature for glycan representation. Proteomics 9:5398-9
Chen, Wei; Stanley, Pamela (2003) Five Lec1 CHO cell mutants have distinct Mgat1 gene mutations that encode truncated N-acetylglucosaminyltransferase I. Glycobiology 13:43-50
Haltiwanger, Robert S; Stanley, Pamela (2002) Modulation of receptor signaling by glycosylation: fringe is an O-fucose-beta1,3-N-acetylglucosaminyltransferase. Biochim Biophys Acta 1573:328-35
Lee, J; Sundaram, S; Shaper, N L et al. (2001) Chinese hamster ovary (CHO) cells may express six beta 4-galactosyltransferases (beta 4GalTs). Consequences of the loss of functional beta 4GalT-1, beta 4GalT-6, or both in CHO glycosylation mutants. J Biol Chem 276:13924-34
Chen, W; Unligil, U M; Rini, J M et al. (2001) Independent Lec1A CHO glycosylation mutants arise from point mutations in N-acetylglucosaminyltransferase I that reduce affinity for both substrates. Molecular consequences based on the crystal structure of GlcNAc-TI. Biochemistry 40:8765-72

Showing the most recent 10 out of 22 publications